Dermatology Life Quality Index use in skin disease guidelines and registries worldwide

R.K. Singh,A.Y. Finlay
DOI: https://doi.org/10.1111/jdv.16701
2020-06-26
Journal of the European Academy of Dermatology and Venereology
Abstract:<p>Guideline authors, researchers and pharmaceutical companies may find it helpful to have access to information about the use of the Dermatology Life Quality Index (DLQI) in national and international guidelines and disease registries. In 2008 we identified only two countries using the DLQI in national guidelines or registries, the UK and Sweden<sup>1</sup>.This number has since greatly increased, influenced by the Rule of Tens concept<sup>2</sup>, a simple way to define current psoriasis disease severity.</p>
dermatology
What problem does this paper attempt to address?